News
2020 December
15
/12
PMV is investing in the Antwerp rehabilitation centre TRAINM, which offers a unique data-driven multidisciplinary rehabilitation treatment for children and adults with a neurological or orthopaedic disorder or injury. The centre also offers rehabilitation to ex-patients who spent time in intensive care due to corona. With a corona-loan of 800,000 EUR,
2020 July
28
/07
Sequana Medical NV (Euronext Brussels: SEQUA), an innovator in the management of fluid overload in liver disease, malignant ascites and heart failure, today announces it has secured a €7.3 million debt financing through PMV subordinated loan agreements, of which €1.4 million will be convertible for new shares of the Company.
27
/07
Indigo Diabetes nv, a young high-tech medical device company that develops medical solutions using nanophotonics, today announced the conclusion of a €38 million Series B funding round to further develop its promising Multi-Biomarker Sensor for people with diabetes.
2018 March
28
/03
Antwerp, March 28th, 2018 - Oxypoint nv, the award-winning University of Antwerp spin-off, bringing innovation to the medical device market for oxygen therapy in hospitals, announced today the closing of a €3.8 million Series A financing round led by the Flemish investment company PMV, together with a family office. The investment round was guided by Wouter Van Roost, who was appointed CEO of the company. The company will use the proceeds to bring its unique proprietary CE-labelled Econo-Comfort™ Oxygen Flowmeter to the European market and to further expand its product range of novel oxygen-therapy administering medical devices.